Clinical trial · Observational
B-Cell Hematologic Malignancy Vaccination Registry
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): No patients enrolled
Summary
Brief summary (as posted)
The goal of this study is to develop a vaccination registry system for Aurora Health Care patients newly diagnosed with MM and other B-Cell Hematologic Malignancies in order to prospectively characterize vaccination history and outcomes such as infection in these patients at Aurora Health Care. Additionally hospitalization rates, cost analysis, infection (influenza, pneumonia, other) related to vaccination in this patient population will be evaluated.
Conditions
Conditions (7)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| B-Cell Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemia | ALIAS | 0.90 |
| Hematological Malignancies | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Lymphocytosis | — | UNRESOLVED | — |
| Lymphoma, Non-Hodgkin | Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Monoclonal Gammopathy of Undetermined Significance | Monoclonal Gammopathy of Undetermined Significance | ONTOLOGY_EXACT | 0.98 |
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
| Waldenstrom Macroglobulinemia | Waldenstrom Macroglobulinemia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- new B-Cell Hematologic Malignancy diagnosis
- description
- All adult patients who are newly diagnosed at Aurora Health Care with the following B-Cell Hematologic Malignancies: Monoclonal gammopathy of undetermined significance (MGUS), Smoldering multiple myeloma (SMM), Multiple myeloma (MM), Waldenstroms Macroglobulinemia (WM), Monoclonal B-cell lymphocytosis (MBL), Chronic lymphocytic leukemia (CLL), or B-Cell Non-Hodgkin lymphoma (NHL).
Primary outcomes (1)
- measure
- vaccination history
- timeFrame
- 10 years
- description
- Information regarding vaccination history will be collected historically and throughout data collection, expected to continue for about 10 years.
Secondary outcomes (3)
- measure
- Survival
- timeFrame
- 10 years
- description
- Survival status will be collected throughout data collection, expected to continue for about 10 years.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Adult patients at Aurora Health Care who are newly diagnosed with: * Monoclonal gammopathy of undetermined significance (MGUS), * Smoldering multiple myeloma (SMM), * Multiple myeloma (MM), * Waldenstroms Macroglobulinemia (WM), * Monoclonal B-cell lymphocytosis (MBL), * Chronic lymphocytic leukemia (CLL), or * B-Cell Non-Hodgkin lymphoma (NHL). Exclusion Criteria: * none
References
Publications (0)
Data not yet available